Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Taiwan - Delayed Quote TWD

Formosa Pharmaceuticals, Inc. (6838.TW)

23.40
-0.30
(-1.27%)
At close: 1:30:08 PM GMT+8
Currency in TWD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
143,356
143,356
31,172
1,315
28,529
Cost of Revenue
24,366
24,366
3,825
982
267
Gross Profit
118,990
118,990
27,347
333
28,262
Operating Expense
286,798
286,798
310,383
382,002
408,270
Operating Income
-167,808
-167,808
-283,036
-381,669
-380,008
Net Non Operating Interest Income Expense
20,612
20,612
8,116
-518
-2,152
Pretax Income
-179,574
-179,574
-300,065
-406,593
-398,422
Tax Provision
21,359
21,359
21,862
-424
2,397
Net Income Common Stockholders
-201,014
-201,014
-321,956
-406,272
-400,883
Diluted NI Available to Com Stockholders
-201,014
-201,014
-321,956
-406,272
-400,883
Basic EPS
-1.43
--
-2.59
-3.86
-4.21
Diluted EPS
-1.43
--
-2.59
-3.86
-4.21
Basic Average Shares
140,569.23
--
124,307.34
108,255
95,212.21
Diluted Average Shares
140,569.23
--
124,307.34
108,255
95,212.21
Total Expenses
311,164
311,164
314,208
382,984
408,537
Net Income from Continuing & Discontinued Operation
-201,014
-201,014
-321,956
-406,272
-400,883
Normalized Income
-194,757.20
-194,757.20
-321,956
-406,272
-400,883
Interest Income
21,181
21,181
12,424
474
55
Interest Expense
569
569
4,308
992
2,207
Net Interest Income
20,612
20,612
8,116
-518
-2,152
EBIT
-179,005
-179,005
-295,757
-405,601
-396,215
EBITDA
-136,726
-136,726
-255,219
-366,200
-358,488
Reconciled Cost of Revenue
24,366
24,366
3,825
982
267
Reconciled Depreciation
42,279
42,279
40,538
39,401
37,727
Net Income from Continuing Operation Net Minority Interest
-201,014
-201,014
-321,956
-406,272
-400,883
Total Unusual Items Excluding Goodwill
-7,821
-7,821
--
--
--
Total Unusual Items
-7,821
-7,821
--
--
--
Normalized EBITDA
-128,905
-128,905
-255,219
-366,200
-358,488
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-1,564.20
-1,564.20
--
--
--
12/31/2021 - 8/5/2024

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

6885.TW BRIM Biotechnology, Inc.
22.70
-2.58%
 
4133.TW Abnova (Taiwan) Corporation
27.35
+3.60%
 
1733.TW Apex Biotechnology Corp.
32.20
+0.31%
 
1762.TW Chunghwa Chemical Synthesis & Biotech Co., Ltd.
28.10
-0.35%
 
6589.TWO EirGenix Inc.
61.50
-0.81%
 
6617.TWO Gongwin Biopharm Holdings Co., Ltd.
82.90
-2.13%
 
4174.TWO OBI Pharma, Inc.
42.20
-9.93%
 
3164.TW GenMont Biotech Incorporation
19.45
+1.04%
 
1734.TW Sinphar Pharmaceutical Co.,Ltd.
31.15
-0.16%
 
6541.TW Tanvex BioPharma, Inc.
59.60
-2.45%